Mirae Asset Global Investments’s Avadel Pharmaceuticals AVDL Stock Holding History

Mirae Asset Global Investments’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,754	Closed	-$57.3K	–	1652
2025 Q3	$57.3K	Buy	3,754 +17	+0.5%	+$221	﹤0.01%	1315
2025 Q2	$33.1K	Buy	3,737 +513	+16%	+$4.51K	﹤0.01%	1318
2025 Q1	$25.8K	Buy	3,224 +13	+0.4%	+$109	﹤0.01%	1360
2024 Q4	$33.8K	Sell	3,211 -271	-8%	-$3.29K	﹤0.01%	1334
2024 Q3	$44.4K	Buy	3,482 +612	+21%	+$9.32K	﹤0.01%	1324
2024 Q2	$41.1K	Buy	+2,870	New	+$46.8K	﹤0.01%	1281

Other funds holding AVDL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global Investments's AVDL Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 3,754 shares — an estimated $57.3K sold.

Mirae Asset Global Investments first reported a position in AVDL in Q2 2024 and held it in 6 quarters. The position peaked at $57.3K in Q3 2025. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

Mirae Asset Global Investments reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Mirae Asset Global Investments sold 3,754 Avadel Pharmaceuticals shares in Q4 2025, an estimated $57.3K.
Mirae Asset Global Investments first reported a position in Avadel Pharmaceuticals in Q2 2024 and held it in 6 quarters.
Mirae Asset Global Investments's Avadel Pharmaceuticals position peaked at $57.3K in Q3 2025.
207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.